Neue Suche | Kongressdetail
mail
Druckansicht
 
 

3rd Dry AMD Therapeutics Summit

Evvnt Promotion / evvnt
-
30.11.2022 - 02.12.2022  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 07:50 - 12:00
 
Kongressthemen
2022 hosts the race between IVERIC Bio and Apellis for regulatory approval of the very first marketable dry AMD treatment. In addition to clinical advances, the field will see plenty of technology advances for more patient-compliant therapeutics, with the favourable one-dose gene therapy approach addition to pipelines, and optimized biomarker technology.

Join our 30+ expert speakers as we tackle the most critical roadblocks preventing your drugs getting the patients who need them.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/1279770-3?pid=4832

Speakers: Abraham Scaria | Chief Scientific Officer | AGTC, Anneke Der Hollander | Senior Principal Scientist and Ophthalmology Lead | AbbVie, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1279770-2?pid=4832
Frau Stephanie Nketia
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2599.00 - USD 3997.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteHelix - Forschung & Beratung WiennewTreeÄrzte der WeltCenter of ExcellenceCharité International AcademyHilfswerk AustriaOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation